AI assistant
UNITED THERAPEUTICS Corp — Director's Dealing 2021
Nov 3, 2021
30320_dirs_2021-11-03_2f5d0775-b747-4828-a998-529d9d5b22f7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: UNITED THERAPEUTICS Corp (UTHR)
CIK: 0001082554
Period of Report: 2021-11-02
Reporting Person: BENKOWITZ MICHAEL (President and COO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-11-02 | Common Stock | M | 4000 | $53.83 | Acquired | 6235 | Direct |
| 2021-11-02 | Common Stock | D | 4000 | $192.20 | Disposed | 2235 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-11-02 | Share Tracking Award | $53.83 | M | 4000 | Disposed | 2023-01-02 | Common Stock (4000) | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Options | $146.03 | 2027-03-15 | Common Stock (63000) | 63000 | Indirect |
| Stock Options | $146.03 | 2027-03-15 | Common Stock (26250) | 26250 | Indirect |
| Stock Options | $146.03 | 2027-03-15 | Common Stock (42940) | 42940 | Indirect |
| Stock Options | $146.03 | 2027-03-15 | Common Stock (69750) | 69750 | Indirect |
| Stock Options | $111.00 | 2028-03-15 | Common Stock (64148) | 64148 | Indirect |
| Stock Options | $111.00 | 2028-03-15 | Common Stock (85531) | 85531 | Indirect |
| Stock Options | $135.42 | 2027-03-15 | Common Stock (187500) | 187500 | Indirect |
| Stock Options | $117.76 | 2027-03-15 | Common Stock (187500) | 187500 | Indirect |
| Stock Options | $120.26 | 2026-03-15 | Common Stock (39200) | 39200 | Indirect |
| Stock Options | $102.11 | 2026-06-26 | Common Stock (52500) | 52500 | Indirect |
Footnotes
F1: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.
F2: This stock option was transferred to a trust beneficially owned by the reporting person on October 23, 2021.
F3: On October 23, 2021 and November 2, 2021, 57,000 and 7,148 shares of this stock option grant, respectively, were transferred to trusts beneficially owned by the reporting person.
F4: This stock option was transferred to a trust beneficially owned by the reporting person on November 2, 2021.